Hepatitis Medicines Approved in the EU (EMA)

Each number has its full source under its own list below.

Medicines authorised in the EU

29 medicines (authorised now). Newest first. Each links to its EMA page.

28Mar2025
Eltrombopag Accord
Active substance: eltrombopag olamine
EMEA/H/C/006459
12Dec2024
Eltrombopag Viatris
Active substance: eltrombopag olamine
EMEA/H/C/006417
18Feb2021
Heplisav B
Active substance: hepatitis B surface antigen
EMEA/H/C/005063
31Jul2020
Hepcludex
Active substance: bulevirtide acetate
EMEA/H/C/004854
25Sep2017
Entecavir Accord
Active substance: Entecavir
EMEA/H/C/004458
18Sep2017
Entecavir Viatris (previously Entecavir Mylan)
Active substance: entecavir monohydrate
EMEA/H/C/004377
26Jul2017
Maviret
Active substance: glecaprevir;pibrentasvir
EMEA/H/C/004430
26Jul2017
Vosevi
Active substance: sofosbuvir;velpatasvir;voxilaprevi
EMEA/H/C/004350
9Jan2017
Vemlidy
Active substance: tenofovir alafenamide fumarate
EMEA/H/C/004169
22Jul2016
Zepatier
Active substance: elbasvir;grazoprevir
EMEA/H/C/004126
6Jul2016
Epclusa
Active substance: sofosbuvir;velpatasvir
EMEA/H/C/004210
15Feb2016
Vaxelis
Active substance: Diphtheria toxoid;tetanus toxoid;Bordetella pertussis antigens: pertussis toxoid, filamentous haemagglutinin, pertactin, fimbriae Types 2 and 3;hepatitis B sur…
EMEA/H/C/003982
17Nov2014
Harvoni
Active substance: ledipasvir;sofosbuvir
EMEA/H/C/003850
16Jan2014
Sovaldi
Active substance: sofosbuvir
EMEA/H/C/002798
17Apr2013
Hexacima
Active substance: hepatitis B surface antigen;Diphtheria toxoid;Bordetella pertussis antigens Pertussis Toxoid Filamentous Haemagglutinin;poliovirus (inactivated) type 1 (Mahone…
EMEA/H/C/002702